Cross-sectional study validates MoCA-B for detecting mild cognitive impairment in Persian speakers, suggesting high accuracy.
The growing number of older people with Mild Cognitive Impairment (MCI) highlights the need for suitable and effective neuropsychological assessments. The Montreal Cognitive Assessment Basic (MoCA-B) is designed to identify MCI in individuals with lower literacy and education levels. This study seeks to validate the use of MoCA-B in the Persian-speaking population. In this cross-sectional study, the original English version of the MoCA-B test was translated into Persian using the forward-backward method. The study involved 60 cognitively healthy aging individuals, 30 with Alzheimer's disease, and 30 MCI patients. All participants met the MMSE, MoCA-B, DSM-5, and Albert's criteria. MoCA-B scores in patients with AD were significantly lower than in the patients with MCI and healthy individuals (P < 0.001). They were significantly lower in MCI than individuals without cognitive impairment (P < 0.001). The cutoff score for discriminating between patients with AD/MCI and individuals without cognitive impairment was 20.5 (sensitivity = 95.0%, specificity = 88.3%, AUC = 0.972). This study shows that the MoCA-B is a suitable screening tool for distinguishing persons with cognitive impairment (MCI and AD) in the Persian-speaking population.
No takes yet. Share an insight, caveat, or question.
Khatoonabadi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: